Novel anxiolytics that act as partial agonists at benzodiazepine receptors
- 30 November 1990
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 11 (11) , 452-456
- https://doi.org/10.1016/0165-6147(90)90126-s
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Studies with Alpidem in Normal Volunteers and Anxious PatientsPharmacopsychiatry, 1990
- Pharmacological and Behavioral Profile of Alpidem as an AnxiolyticPharmacopsychiatry, 1990
- Selectivity for Omega-Receptor Subtypes as a Strategy for the Development of Anxiolytic DrugsPharmacopsychiatry, 1990
- On the Therapeutic Action of Alpidem in Anxiety Disorders: An Overview of the European DataPharmacopsychiatry, 1990
- Relationship of agonist efficacy to changes in GABA sensitivity and anticonvulsant tolerance following chronic benzodiazepine ligand exposureEuropean Journal of Pharmacology, 1989
- Ro 16-6028: A Novel Anxiolytic Acting as a Partial Agonist at the Benzodiazepine ReceptorPharmacopsychiatry, 1988
- Demonstration of the partial agonist profiles of Ro 16-6028 and Ro 17-1812 in mice in vivoEuropean Journal of Pharmacology, 1988
- DIFFERENCES BETWEEN BENZODIAZEPINESThe Lancet, 1988
- RO 16-6028,a benzodiazepine receptor partial agonist, does not exhibit anticonvulasant tolerance in miceEuropean Journal of Pharmacology, 1988
- Pharmacological profiles in vivo of benzodiazepine receptor ligandsDrug Development Research, 1988